Back

All-cause mortality in hypertrophic cardiomyopathy (HCM) compared to the general population in England and the US

22 May 2023 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - hypertrophic cardiomyopathy 2 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Maria Teresa Tome Esteban

St George's Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Betablockers or calcium channel blockers in hypertrophic cardiomyopathy
Doctor G. Pinto (Rozzano, IT)
Abstract Slides
Presentation thumbnail
Myocardial extracellular space expansion and diastolic function is related to QRS-T angle in patients with hypertrophic cardiomyopathy
Doctor H. Chung (Seoul, KR)
Abstract Slides
Presentation thumbnail
Septal microsphere embolization in hypertrophic obstructive cardiomyopathy: a quindecennial single-center experience
Doctor E. Alyaydin (Dortmund, DE)
Abstract Slides
Presentation thumbnail
No variant tranythyretin amyloidosis is found in a large non-red-flag selected cardiomyopathy population
Doctor H. Takacs (Szeged, HU)
Abstract Slides
Presentation thumbnail
Long-term cardiovascular outcomes and events by New York Heart Association class in patients with obstructive hypertrophic cardiomyopathy in England
Mr M. Hurst (Cardiff, GB) Doctor B. Sandler (GB)
Abstract Slides

Access the full session

Session thumbnail
Myocardial disease - hypertrophic cardiomyopathy 2

The Event

Event poster

Heart Failure 2023

22 May 2023 13:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources